Literature DB >> 23053030

[Importance of radical prostatectomy for patients older than 70 years].

C Thomas1, F C Roos, J W Thüroff.   

Abstract

Surgical treatment of prostate cancer (PCa) in patients older than 70 years is controversially discussed. Although the prevalence and presumably also the aggressiveness of PCa increase with age, a survival advantage by radical prostatectomy (RPx) is questionable. The current review will discuss the oncological outcome of RPx in the elderly. Moreover, the pros and cons of different surgical approaches will be evaluated.

Entities:  

Mesh:

Year:  2012        PMID: 23053030     DOI: 10.1007/s00120-012-3010-7

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  21 in total

Review 1.  Global patterns of cancer incidence and mortality rates and trends.

Authors:  Ahmedin Jemal; Melissa M Center; Carol DeSantis; Elizabeth M Ward
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

2.  Patients aged more than 70 had higher risk of locally advanced prostate cancers and biochemical recurrence in Korea.

Authors:  Jung Kwon Kim; Sung Yong Cho; Chang Wook Jeong; Seung Bae Lee; Ja Hyeon Ku; Sung Kyu Hong; Seok-Soo Byun; Cheol Kwak; Hyeon Hoe Him; Sang Eun Lee; Hyeon Jeong
Journal:  BJU Int       Date:  2012-02-07       Impact factor: 5.588

3.  Impact of surgical technique (open vs laparoscopic vs robotic-assisted) on pathological and biochemical outcomes following radical prostatectomy: an analysis using propensity score matching.

Authors:  Ahmed Magheli; Mark L Gonzalgo; Li-Ming Su; Thomas J Guzzo; George Netto; Elizabeth B Humphreys; Misop Han; Alan W Partin; Christian P Pavlovich
Journal:  BJU Int       Date:  2010-11-02       Impact factor: 5.588

4.  EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease.

Authors:  Axel Heidenreich; Joaquim Bellmunt; Michel Bolla; Steven Joniau; Malcolm Mason; Vsevolod Matveev; Nicolas Mottet; Hans-Peter Schmid; Theo van der Kwast; Thomas Wiegel; Filliberto Zattoni
Journal:  Eur Urol       Date:  2010-10-28       Impact factor: 20.096

5.  Perioperative outcomes of robot-assisted radical prostatectomy compared with open radical prostatectomy: results from the nationwide inpatient sample.

Authors:  Quoc-Dien Trinh; Jesse Sammon; Maxine Sun; Praful Ravi; Khurshid R Ghani; Marco Bianchi; Wooju Jeong; Shahrokh F Shariat; Jens Hansen; Jan Schmitges; Claudio Jeldres; Craig G Rogers; James O Peabody; Francesco Montorsi; Mani Menon; Pierre I Karakiewicz
Journal:  Eur Urol       Date:  2011-12-22       Impact factor: 20.096

6.  Assessment of lymph node yield after pelvic lymph node dissection in men with prostate cancer: a comparison between robot-assisted radical prostatectomy and open radical prostatectomy in the modern era.

Authors:  Matthew D Truesdale; Daniel J Lee; Philippa J Cheetham; Gregory W Hruby; Andrew T Turk; Ketan K Badani
Journal:  J Endourol       Date:  2010-07       Impact factor: 2.942

Review 7.  Can an index of aging be constructed for evaluating treatments to retard aging rates? A 2,462-person study.

Authors:  R Hochschild
Journal:  J Gerontol       Date:  1990-11

Review 8.  Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a critical review of outcomes reported by high-volume centers.

Authors:  Rafael F Coelho; Bernardo Rocco; Manoj B Patel; Marcelo A Orvieto; Sanket Chauhan; Vincenzo Ficarra; Sara Melegari; Kenneth J Palmer; Vipul R Patel
Journal:  J Endourol       Date:  2010-10-13       Impact factor: 2.942

9.  Impact of patient age at treatment on outcome following radical retropubic prostatectomy for prostate cancer.

Authors:  Sameer A Siddiqui; Shomik Sengupta; Jeffrey M Slezak; Eric J Bergstralh; Bradley C Leibovich; Robert P Myers; Horst Zincke; Michael L Blute
Journal:  J Urol       Date:  2006-03       Impact factor: 7.450

10.  Adequacy of lymphadenectomy among men undergoing robot-assisted laparoscopic radical prostatectomy.

Authors:  Matthew R Cooperberg; Christopher J Kane; Janet E Cowan; Peter R Carroll
Journal:  BJU Int       Date:  2009-06-22       Impact factor: 5.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.